CYP2C19 genotype–guided antiplatelet therapy in ST-segment elevation myocardial infarction patients—Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study

Autor: Bergmeijer, Thomas O., Janssen, Paul W.A., Schipper, Jurjan C., Qaderdan, Khalid, Ishak, Maycel, Ruitenbeek, Rianne S., Asselbergs, Folkert W., van ‘t Hof, Arnoud W.J., Dewilde, Willem J.M., Spanó, Fabrizio, Herrman, Jean-Paul R., Kelder, Johannes C., Postma, Maarten J., de Boer, Anthonius, Deneer, Vera H.M., ten Berg, Jurriën M.
Zdroj: In American Heart Journal July 2014 168(1):16-22
Databáze: ScienceDirect